A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases

European Journal of Cancer

Volumn 45, Issue 10, 2009, Pages 1748-1756

  Stang, Axel ^a   Fischbach, Roman ^a   Teichmann, Wolfgang ^a   Bokemeyer, Carsten ^b   Braumann, Dietrich ^a  

^a Asklepios Clinic Altona   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Colorectal cancer; Liver metastases; Prognosis; Radiofrequency ablation; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CATHETER ABLATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; PROGNOSIS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 66949119654     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.03.012     Document Type: Article

References (45)

1. Seymour M.T., Maughan T.S., Ledermann J.A., et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomized controlled trial. Lancet 370 (2007) 143-152
2. Koopmann M., Antonini N.F., Douma J., et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomized trial. Lancet 370 (2007) 135-142
3. Loupakis F., Masi G., Vasile E., and Falcone A. First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?. Curr Opin Oncol 20 (2008) 459-465
4. Pawlik T.M., Schulick R.D., and Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 13 (2008) 51-64
5. Tomlinson J.S., Jarnagin W.R., DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25 (2007) 4575-4580
6. Poston G.J., Adam R., Alberts S., et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23 (2005) 7125-7134
7. Adam R., Delvert V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-658
8. Ahmad A., Chen S.L., and Bilchik A.J. Role of repeated hepatectomy in multimodal treatment of hepatic colorectal metastases. Arch Surg 142 (2007) 526-532
9. Stang A., Keles H., von Seydewitz C., et al. Percutanous and intraoperative ultrasonography guided radiofrequency ablation of hepatic tumors. Ultraschall Med 28 (2007) 181-188
10. Garrean S., Hering J., Saied A., Helton S., and Espat N.J. Radiofrequency of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195 (2008) 508-520
11. McGrane S., McSweeeney S.E., and Maher M.M. Which patients will benefit from percutaneous radiofrequency ablation of colorectal cancer metastases ? A critically appaised topic. Abdom Imaging 33 (2008) 48-53
12. Benoist S., and Nordlinger B. Radiofrequency ablation in liver tumours. Ann Oncol 15 Suppl. 4 (2004) iv313-iv317
13. Ruers T, van Coevorden F, Pierie JPJ, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): interim results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). J Clin Oncol 2008, ASCO annual meeting proceedings 2008;26:4012 [abstract].
14. Solbiati L., Livrhagi T., Goldberg S.N., et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 (2001) 159-166
15. Gillams A.R., and Lees W.R. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 30 (2005) 419-426
16. Jakobs T.F., Hoffmann R.T., Trumm C., Reiser M.F., and Helmberger T.K. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 26 (2006) 671-680
17. Amersi F.F., Mc-Elrath-Garza A., Ahmad A., et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141 (2006) 581-588
18. Abitabile P., Hartl U., Lange J., and Maurer C.A. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. ESJO 33 (2007) 67-71
19. Siperstein A., Berber E., Ballerm N., and Rikesh T. Survival after radiofrequency ablation of colorectal metastases: 10-year experience. Ann Surg 246 (2007) 559-567
20. Sorensen S.M., Mortensen F.V., and Nielsen D.T. Radiofrequency of colorectal liver metastases: long-term survival. Acta Radiol 48 (2007) 253-258
21. Veltri A., Sacchetto P., Tosetti I., Pagano E., Fava C., and Gandini G. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31 (2008) 948-956
22. Gillams A.R., and Lees W.R. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 17 (2008) 712-717
23. Oshowo A., Gillams A., Harrison E., Lees W.R., and Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Brit J Surg 90 (2003) 1240-1243
24. Aloia T.A., Vauthey J.N., Loyer E., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 (2006) 460-467
25. White R.R., Avital I., Sofocleous C.T., et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal metastasis. J Gastrointest Surg 11 (2007) 256-263
26. Park I.J., Kim H.C., Yu C.S., Kim P.N., Won H.J., and Kim J.C. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 15 (2008) 227-232
27. Hur H, Ko YT, Min BS, et al. Comparative study of resection and radiofrequency of solitary colorectal metastases. Am J Surg 2008 [ePub before of print].
28. Pawlik T.M., Izzo F., Cohen D.S., Morris J.S., and Curley S.A. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10 (2003) 1059-1069
29. Elias D., Baton O., Sideris L., et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 135 (2005) 657-664
30. Kornprat P., Jarnagin W.R., DeMatteo R.P., Fog Y., Blumgart L.H., and D'Angelica M. Role of intraoperative thermal ablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg 142 (2007) 1087-1092
31. Ogata Y., Uchida S., Hisaka T., et al. Intraoperative thermal ablation therapy for small colorectal metastases to the liver. Hepato-Gastroenterology 55 (2008) 550-556
32. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcome following hepatic resection, radiofrequncy ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-827
33. Ruers T.J.M., Joosten J.J., Wiering B., et al. Comparison between local ablative therapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 14 (2007) 1161-1169
34. Machi J., Oishi A.J., Sumida K., et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognosic factors and effectiveness in first- and second-line management. Cancer J 12 (2006) 318-326
35. Mulier S., Ni Y., Jamart J., Ruers T., Marchal G., and Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242 (2005) 158-171
36. Van Duijnhoven F.H., Jansen M.C., Junggeburt J.M.C., et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal metastases. Ann Surg Oncol 13 (2006) 651-658
37. Ni Y., Mulier S., Miao Y., Michel L., and Marchal G. A review of the general aspect of radiofrequency ablation. Abdom Imaging 30 (2005) 381-400
38. Ahmad A., Chen S.L., Kavanagh M.A., Allegra D.P., and Bilchik A.J. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?. Am Surg 72 (2006) 875-879
39. Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: a contradication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061
40. Mulier S., Ni Y., Jamart J., Michel L., Marchal G., and Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol 15 (2008) 144-157
41. Curley S. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol 15 (2008) 11-13
42. De Meijer V.E., and IJzermans J.N.M. A place for radiofrequency ablation in the treatment of resectable colorectal metastases?. Ann Surg Oncol 15 (2008) 2063
43. Berber E., Pelley R., and Siperstein A.E. Predictor of survival after radiofrequency thermal ablation of colorectal metastases to the liver: a prospective study. J Clin Oncol 23 (2005) 1358-1364
44. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
45. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77 (1996) 1254-1262